Doris B. Strader

8.7k total citations · 4 hit papers
37 papers, 6.4k citations indexed

About

Doris B. Strader is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Doris B. Strader has authored 37 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 23 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Doris B. Strader's work include Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (18 papers). Doris B. Strader is often cited by papers focused on Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (18 papers). Doris B. Strader collaborates with scholars based in United States and Netherlands. Doris B. Strader's co-authors include Leonard B. Seeff, David L. Thomas, Marc G. Ghany, Teresa L. Wright, David R. Nelson, David C. Metz, Murray Orbuch, James A. M. McHugh, Jean L. Grem and Edward A. Belongia and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Hepatology.

In The Last Decade

Doris B. Strader

35 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

2008 2.3k citations Marc G. Ghany, Doris B. Strader et al. Hepatology profile →
Diagnosis, management, and treatment of hepatitis C†

2004 1.3k citations Doris B. Strader, Teresa L. Wright et al. Hepatology profile →
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

2011 828 citations Marc G. Ghany, David R. Nelson et al. Hepatology profile →
National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B

2009 535 citations Michael F. Sorrell, Edward A. Belongia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Doris B. Strader United States	22	5.2k	5.0k	609	498	422	37	6.4k
Alessio Aghemo Italy	43	5.7k 1.1×	5.8k 1.2×	1.3k 2.1×	460 0.9×	346 0.8×	245	8.0k
Jaw‐Ching Wu Taiwan	38	3.0k 0.6×	3.3k 0.7×	570 0.9×	456 0.9×	188 0.4×	145	4.9k
Robert Flisiak Poland	41	5.4k 1.0×	5.4k 1.1×	1.5k 2.5×	340 0.7×	256 0.6×	364	7.8k
Luigi Elio Adinolfi Italy	43	4.5k 0.9×	3.8k 0.8×	305 0.5×	200 0.4×	498 1.2×	139	6.4k
David Wong Canada	30	3.8k 0.7×	3.7k 0.7×	569 0.9×	181 0.4×	248 0.6×	126	5.6k
Chihiro Morishima United States	39	3.2k 0.6×	3.2k 0.6×	819 1.3×	626 1.3×	241 0.6×	82	6.0k
Jeanne G. Waggoner United States	33	3.6k 0.7×	3.9k 0.8×	335 0.6×	344 0.7×	499 1.2×	58	5.2k
Hiroshi Yotsuyanagi Japan	38	3.3k 0.6×	3.0k 0.6×	1.1k 1.8×	419 0.8×	224 0.5×	232	5.5k
Daniele Prati Italy	39	3.5k 0.7×	2.5k 0.5×	637 1.0×	251 0.5×	172 0.4×	174	5.4k
Maurizio Pompili Italy	39	2.9k 0.6×	3.2k 0.6×	339 0.6×	609 1.2×	165 0.4×	231	6.0k

Countries citing papers authored by Doris B. Strader

Since Specialization

Citations

This map shows the geographic impact of Doris B. Strader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris B. Strader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris B. Strader more than expected).

Fields of papers citing papers by Doris B. Strader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris B. Strader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris B. Strader. The network helps show where Doris B. Strader may publish in the future.

Co-authorship network of co-authors of Doris B. Strader

This figure shows the co-authorship network connecting the top 25 collaborators of Doris B. Strader. A scholar is included among the top collaborators of Doris B. Strader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris B. Strader. Doris B. Strader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strader, Doris B., et al.. (2019). Utility of laboratory monitoring during hepatitis C treatment with ribavirin‐free direct‐acting antiviral regimens. Journal of Viral Hepatitis. 26(6). 778–781. 3 indexed citations

Ghany, Marc G., David R. Nelson, Doris B. Strader, David L. Thomas, & Leonard B. Seeff. (2011). An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 54(4). 1433–1444. 828 indexed citations breakdown →

Sorrell, Michael F., Edward A. Belongia, José Costa, et al.. (2009). National Institutes of Health consensus development conference statement: Management of hepatitis B # † ‡ п. Hepatology. 49(Suppl. 5). S4–S12. 88 indexed citations

Ghany, Marc G., Doris B. Strader, David L. Thomas, & Leonard B. Seeff. (2008). Diagnosis, management, and treatment of hepatitis C: An update # † ‡. Hepatology. 49(4). 1335–1374. 2271 indexed citations breakdown →

Yeh, Matthew M., et al.. (2005). More Severe Parenchymal Injury in Chronic Hepatitis C Acquired by Recent Injection Drug Use. Journal of Clinical Gastroenterology. 39(8). 722–727. 3 indexed citations

Strader, Doris B.. (2005). Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations. Clinical Infectious Diseases. 41(Supplement_1). S7–S13. 40 indexed citations

Strader, Doris B., Teresa L. Wright, David L. Thomas, & Leonard B. Seeff. (2004). Diagnosis, management, and treatment of hepatitis C†. Hepatology. 39(4). 1147–1171. 1329 indexed citations breakdown →

Rao, Manjunath N., Philippe Marmillot, Maokaı̈ Gong, et al.. (2003). Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism. 52(10). 1287–1294. 92 indexed citations

Strader, Doris B., Bruce R. Bacon, Karen L. Lindsay, et al.. (2002). Use of complementary and alternative medicine in patients with liver disease. The American Journal of Gastroenterology. 97(9). 2391–2397. 129 indexed citations

10.

Strader, Doris B.. (2002). Understudied populations with hepatitis C. Hepatology. 36. s226–s236. 40 indexed citations

11.

Strader, Doris B. & L. B. Seeff. (2001). Hepatitis C : A Brief Clinical Overview. ILAR Journal. 42(2). 107–116. 16 indexed citations

12.

Rao, Manjunath N., Qinghong Liu, Philippe Marmillot, et al.. (2000). High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function. Metabolism. 49(11). 1406–1410. 37 indexed citations

13.

Monga, Satdarshan P., Robert G. Wadleigh, Ambika Sharma, et al.. (2000). Intratumoral Therapy of Cisplatin/Epinephrine Injectable Gel for Palliation in Patients With Obstructive Esophageal Cancer. American Journal of Clinical Oncology. 23(4). 386–392. 55 indexed citations

14.

Strader, Doris B., et al.. (1996). The natural history of chronic hepatitis C infection. European Journal of Gastroenterology & Hepatology. 8(4). 324–328. 41 indexed citations

15.

Strader, Doris B. & Leonard B. Seeff. (1996). New Hepatitis A Vaccines and Their Role in Prevention. Drugs. 51(3). 359–366. 5 indexed citations

16.

Strader, Doris B., Stanley B. Benjamin, Murray Orbuch, et al.. (1995). Esophageal Function and Occurrence of Barrett’s Esophagus in Zollinger-Ellison Syndrome. Digestion. 56(5). 347–356. 20 indexed citations

17.

Knight, Martha, Kazuyuki Takahashi, Bhaskar Chandrasekhar, et al.. (1995). Inhibitory cyclic analogues and chlorambucil derivatives of bombesin-like peptides. Peptides. 16(6). 1109–1115. 6 indexed citations

18.

Metz, David C., et al.. (1993). Use of omeprazole in Zollinger‐Ellison syndrome: a prospective nine‐year study of efficacy and safety. Alimentary Pharmacology & Therapeutics. 7(6). 597–610. 71 indexed citations

19.

Metz, David C., Richard V. Benya, Vitaly A. Fishbeyn, et al.. (1993). Prospective study of the need for long‐term antisecretory therapy in patients with Zollinger—Ellison syndrome following successful curative gastrinoma resection. Alimentary Pharmacology & Therapeutics. 7(3). 247–257. 23 indexed citations

20.

Pisegna, Joseph R., John L. Doppman, Doris B. Strader, et al.. (1993). An evaluation of human recombinant α interferon in patients with metastatic gastrinoma. Gastroenterology. 105(4). 1179–1183. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact